EV/EBITDA:
185.85+2.51(+1.37%)Summary
- As of today, ALNY EV/EBITDA is 185.85, with a rise of +2.51 (+1.37%) during the most recent trading session on November 28, 2025.
- Over the past year, ALNY EV/EBITDA has increased by +483.01 (+162.54%).
- ALNY EV/EBITDA is now -39.06% below its all-time high of 304.97.
Performance
ALNY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ALNY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.4% | +1.4% | +1.4% |
| 1M1 Month | -1.1% | -1.1% | -1.1% |
| 3M3 Months | +147.8% | +2.1% | +1.1% |
| 6M6 Months | +161.7% | +49.9% | +48.2% |
| YTDYTD | +196.6% | +95.8% | +91.8% |
| 1Y1 Year | +162.5% | +83.1% | +78.3% |
| 5Y5 Years | +1053.1% | +300.3% | +241.1% |
ALNY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 190.41 | -2.4% | 174.43 | +6.5% |
| 3M | 3-Month | 201.82 | -7.9% | -419.71 | +144.3% |
| 6M | 6-Month | 201.82 | -7.9% | -419.71 | +144.3% |
| 1Y | 1-Year | 201.82 | -7.9% | -419.71 | +144.3% |
| 3Y | 3-Year | 304.97 | -39.1% | -419.71 | +144.3% |
| 5Y | 5-Year | 304.97 | -39.1% | -419.71 | +144.3% |
| All-Time | All-Time | 304.97 | -39.1% | -419.71 | +144.3% |
ALNY EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 185.85(+196.5%) |
| 2024 | -192.50(-89.4%) |
| 2023 | -101.66(-209.8%) |
| 2022 | -32.81(-1.0%) |
| 2021 | -32.50(-52.5%) |
| 2020 | -21.31(-52.9%) |
| 2019 | -13.94(-64.4%) |
| Date | Value |
|---|---|
| 2018 | -8.48(+62.4%) |
| 2017 | -22.54(-236.9%) |
| 2016 | -6.69(+73.3%) |
| 2015 | -25.02(+36.5%) |
| 2014 | -39.42(+15.4%) |
| 2013 | -46.58(-204.2%) |
| 2012 | -15.31 |
FAQ
- What is Alnylam Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Alnylam Pharmaceuticals, Inc.?
- What is ALNY EV/EBITDA year-to-date change?
- What is Alnylam Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Alnylam Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of ALNY is 185.85
What is the all-time high EV/EBITDA for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high EV/EBITDA is 304.97
What is ALNY EV/EBITDA year-to-date change?
Alnylam Pharmaceuticals, Inc. EV/EBITDA has changed by +378.35 (+196.55%) since the beginning of the year
What is Alnylam Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, ALNY EV/EBITDA has changed by +483.01 (+162.54%)